SherbyNet - /page/wikibook/entry.mu

Micron Document

<!DOCTYPE html>

<title>Reprogramming</title>

</head>

Reprogramming

</h1>

</header>

/* start https://en.wikipedia.org/ */

.mw-parser-output .hatnote{font-style:italic}.mw-parser-output div.hatnote{padding-left:1.6em;margin-bottom:0.5em}.mw-parser-output .hatnote i{font-style:normal}.mw-parser-output .hatnote+link+.hatnote{margin-top:-0.5em}@media print{body.ns-0 .mw-parser-output .hatnote{display:none!important}}

/* end https://en.wikipedia.org/ */

</style><div role="note" class="hatnote navigation-not-searchable">This article is about the epigenetic phenomenon. For the writing of computer code, see <a href="Computer_programming" title="Computer programming">computer programming</a>.</div>

In biology, reprogramming refers to erasure and remodeling of <a href="Epigenetics" title="Epigenetics">epigenetic</a> marks, such as <a href="DNA_methylation" title="DNA methylation">DNA methylation</a>, during mammalian development or in cell culture.<a href="#cite_note-1">[1]</a> Such control is also often associated with alternative covalent modifications of <a href="Histones" class="mw-redirect" title="Histones">histones</a>.

Reprogrammings that are both large scale (10% to 100% of epigenetic marks) and rapid (hours to a few days) occur at three life stages of mammals. Almost 100% of epigenetic marks are reprogrammed in two short periods early in development after <a href="Fertilization" class="mw-redirect" title="Fertilization">fertilization</a> of an <a href="Egg_cell" title="Egg cell">ovum</a> by a <a href="Sperm" title="Sperm">sperm</a>. In addition, almost 10% of <a href="DNA_methylation" title="DNA methylation">DNA methylations</a> in <a href="Neuron" title="Neuron">neurons</a> of the hippocampus can be rapidly altered during formation of a strong fear memory.

After fertilization in mammals, <a href="DNA_methylation" title="DNA methylation">DNA methylation</a> patterns are largely erased and then re-established during early embryonic development. Almost all of the methylations from the parents are erased, first during early <a href="Embryogenesis" class="mw-redirect" title="Embryogenesis">embryogenesis</a>, and again in <a href="Gametogenesis" title="Gametogenesis">gametogenesis</a>, with demethylation and remethylation occurring each time. Demethylation during early embryogenesis occurs in the preimplantation period. After a sperm fertilizes an <a href="Egg_cell" title="Egg cell">ovum</a> to form a <a href="Zygote" title="Zygote">zygote</a>, rapid <a href="DNA_demethylation" title="DNA demethylation">DNA demethylation</a> of the paternal DNA and slower demethylation of the maternal DNA occurs until formation of a <a href="Morula" class="mw-redirect" title="Morula">morula</a>, which has almost no methylation. After the <a href="Blastocyst" title="Blastocyst">blastocyst</a> is formed, methylation can begin, and with formation of the <a href="Epiblast" title="Epiblast">epiblast</a> a wave of methylation then takes place until the <a href="Implantation_(embryology)" title="Implantation (embryology)">implantation</a> stage of the embryo. Another period of rapid and almost complete demethylation occurs during gametogenesis within the primordial <a href="Germ_cell" title="Germ cell">germ cells</a> (PGCs). Other than the PGCs, in the post-implantation stage, methylation patterns in somatic cells are stage- and <a href="Tissue_(biology)" title="Tissue (biology)">tissue</a>-specific with changes that presumably define each individual <a href="Cell_type" title="Cell type">cell type</a> and last stably over a long time.<a href="#cite_note-2">[2]</a>

<div class="mw-heading mw-heading2"><h2 id="Embryonic_development">Embryonic development</h2></div>

The mouse <a href="Sperm" title="Sperm">sperm</a> <a href="Genome" title="Genome">genome</a> is 80–90% <a href="5-Methylcytosine" title="5-Methylcytosine">methylated</a> at its <a href="CpG_site" title="CpG site">CpG sites</a> in DNA, amounting to about 20 million methylated sites. After <a href="Fertilization" class="mw-redirect" title="Fertilization">fertilization</a>, the paternal chromosome is almost completely <a href="DNA_demethylation" title="DNA demethylation">demethylated</a> in six hours by an active process, before DNA replication (blue line in Figure). In the mature <a href="Oocyte" title="Oocyte">oocyte</a>, about 40% of its CpG sites are methylated. Demethylation of the maternal chromosome largely takes place by blockage of the methylating <a href="Enzyme" title="Enzyme">enzymes</a> from acting on maternal-origin DNA and by dilution of the methylated maternal DNA during replication (red line in Figure). The <a href="Morula" class="mw-redirect" title="Morula">morula</a> (at the 16 cell stage), has only a small amount of <a href="DNA_methylation" title="DNA methylation">DNA methylation</a> (black line in Figure). Methylation begins to increase at 3.5 days after fertilization in the <a href="Blastocyst" title="Blastocyst">blastocyst</a>, and a large wave of methylation then occurs on days 4.5 to 5.5 in the <a href="Epiblast" title="Epiblast">epiblast</a>, going from 12% to 62% methylation, and reaching maximum level after implantation in the uterus.<a href="#cite_note-pmid25476147-3">[3]</a> By day seven after fertilization, the newly formed <a href="Germ_cell" title="Germ cell">primordial germ cells</a> (PGC) in the implanted <a href="Embryo" title="Embryo">embryo</a> segregate from the remaining <a href="Somatic_cell" title="Somatic cell">somatic cells</a>. At this point the PGCs have about the same level of methylation as the somatic cells.

The newly formed primordial germ cells (PGC) in the implanted embryo devolve from the somatic cells. At this point the PGCs have high levels of methylation. These cells migrate from the epiblast toward the <a href="Gonadal_ridge" class="mw-redirect" title="Gonadal ridge">gonadal ridge</a>. Now the cells are rapidly proliferating and beginning demethylation in two waves. In the first wave, demethylation is by replicative dilution, but in the second wave demethylation is by an active process. The second wave leads to demethylation of specific <a href="Locus_(genetics)" title="Locus (genetics)">loci</a>. At this point the PGC genomes display the lowest levels of DNA methylation of any cells in the entire <a href="Biological_life_cycle" title="Biological life cycle">life cycle</a> [at embryonic day 13.5 (E13.5), see the second figure in this section].<a href="#cite_note-Zeng-4">[4]</a>

After fertilization some cells of the newly formed embryo migrate to the germinal ridge and will eventually become the <a href="Germ_cell" title="Germ cell">germ cells</a> (sperm and oocytes) of the next generation. Due to the phenomenon of <a href="Genomic_imprinting" title="Genomic imprinting">genomic imprinting</a>, maternal and paternal genomes are differentially marked and must be properly reprogrammed every time they pass through the germline. Therefore, during the process of <a href="Gametogenesis" title="Gametogenesis">gametogenesis</a> the primordial germ cells must have their original biparental <a href="DNA_methylation" title="DNA methylation">DNA methylation</a> patterns erased and re-established based on the sex of the transmitting parent.

After fertilization, the paternal and maternal genomes are demethylated in order to erase their epigenetic signatures and acquire <a href="Totipotency" class="mw-redirect" title="Totipotency">totipotency</a>. There is asymmetry at this point: the male pronucleus undergoes a quick and active demethylation. Meanwhile the female pronucleus is demethylated passively during consecutive cell divisions. The process of <a href="DNA_demethylation" title="DNA demethylation">DNA demethylation</a> involves <a href="Base_excision_repair" title="Base excision repair">base excision repair</a> and likely other DNA-repair-based mechanisms.<a href="#cite_note-pmid27916276-5">[5]</a> Despite the global nature of this process, there are certain sequences that avoid it, such as <a href="Differentially_methylated_regions" class="mw-redirect" title="Differentially methylated regions">differentially methylated regions</a> (DMRS) associated with imprinted genes, <a href="Retrotransposon" title="Retrotransposon">retrotransposons</a> and <a href="Centromeric" class="mw-redirect" title="Centromeric">centromeric</a> <a href="Heterochromatin" title="Heterochromatin">heterochromatin</a>. Remethylation is needed again to differentiate the embryo into a complete organism.<a href="#cite_note-pmid23166394-6">[6]</a>

In vitro manipulation of pre-implantation embryos has been shown to disrupt methylation patterns at imprinted loci<a href="#cite_note-7">[7]</a> and plays a crucial role in cloned animals.<a href="#cite_note-8">[8]</a>

<div class="mw-heading mw-heading2"><h2 id="Learning_and_memory">Learning and memory</h2></div>

<a href="Learning" title="Learning">Learning</a> and memory have levels of permanence, differing from other mental processes such as thought, language, and consciousness, which are temporary in nature. Learning and memory can be either accumulated slowly (multiplication tables) or rapidly (touching a hot stove), but once attained, can be recalled into conscious use for a long time. Rats subjected to one instance of <a href="Fear_conditioning" title="Fear conditioning">contextual fear conditioning</a> create an especially strong long-term memory. At 24 h after training, 9.17% of the genes in the rat genomes of <a href="Hippocampus" title="Hippocampus">hippocampus</a> neurons were found to be <a href="Differentially_methylated_region" title="Differentially methylated region">differentially methylated</a>. This included more than 2,000 differentially methylated genes at 24 hours after training, with over 500 genes being demethylated.<a href="#cite_note-pmid28620075-9">[9]</a> The hippocampus region of the brain is where contextual fear memories are first stored (see figure of the brain, this section), but this storage is transient and does not remain in the hippocampus. In rats contextual fear conditioning is abolished when the hippocampus is subjected to hippocampectomy just 1 day after conditioning, but rats retain a considerable amount of contextual fear when a long delay (28 days) is imposed between the time of conditioning and the time of hippocampectomy.<a href="#cite_note-pmid16120461-10">[10]</a>

<div class="mw-heading mw-heading2"><h2 id="Molecular_stages">Molecular stages</h2></div>

Three molecular stages are required for reprogramming the <a href="DNA_methylation" title="DNA methylation">DNA methylome</a>. Stage 1: Recruitment. The enzymes needed for reprogramming are recruited to genome sites that require demethylation or methylation. Stage 2: Implementation. The initial enzymatic reactions take place. In the case of methylation, this is a short step that results in the methylation of <a href="Cytosine" title="Cytosine">cytosine</a> to <a href="5-methylcytosine" class="mw-redirect" title="5-methylcytosine">5-methylcytosine</a>. Stage 3: <a href="Base_excision_DNA_repair" class="mw-redirect" title="Base excision DNA repair">Base excision DNA repair</a>. The intermediate products of demethylation are catalysed by specific enzymes of the base excision DNA repair pathway that finally restore cystosine in the DNA sequence.

The Figure in this section indicates the central roles of ten-eleven translocation <a href="TET_enzymes" title="TET enzymes">methylcytosine dioxygenases (TETs)</a> in the demethylation of 5-methylcytosine to form cytosine.<a href="#cite_note-Bayraktar-12">[12]</a> As reviewed in 2018,<a href="#cite_note-Bayraktar-12">[12]</a> 5mC is very often initially oxidized by TET dioxygenases to generate <a href="5-hydroxymethylcytosine" class="mw-redirect" title="5-hydroxymethylcytosine">5-hydroxymethylcytosine</a> (5hmC). In successive steps (see Figure) TET enzymes further hydroxylate 5hmC to generate <a href="5-formylcytosine" class="mw-redirect" title="5-formylcytosine">5-formylcytosine</a> (5fC) and <a href="5-carboxylcytosine" class="mw-redirect" title="5-carboxylcytosine">5-carboxylcytosine</a> (5caC). <a href="Thymine-DNA_glycosylase" title="Thymine-DNA glycosylase">Thymine-DNA glycosylase</a> (TDG) recognizes the intermediate bases 5fC and 5caC and excises the <a href="Glycosidic_bond" title="Glycosidic bond">glycosidic bond</a> resulting in an <a href="AP_site" title="AP site">apyrimidinic site</a> (AP site). In an alternative oxidative deamination pathway, 5hmC can be oxidatively deaminated by <a href="APOBEC" title="APOBEC">APOBEC</a> (AID/APOBEC) deaminases to form 5-hydroxymethyluracil (5hmU) or 5mC can be converted to <a href="Thymine" title="Thymine">thymine</a> (Thy). 5hmU can be cleaved by TDG, <a href="SMUG1" title="SMUG1">SMUG1</a>, <a href="NEIL1" title="NEIL1">NEIL1</a>, or <a href="MBD4" title="MBD4">MBD4</a>. AP sites and T:G mismatches are then repaired by base excision repair (BER) enzymes to yield cytosine (Cyt).

<div class="mw-heading mw-heading3"><h3 id="TET_family">TET family</h3></div>

The isoforms of the <a href="TET_enzymes" title="TET enzymes">TET enzymes</a> include at least two isoforms of TET1, one of <a href="Tet_methylcytosine_dioxygenase_2" title="Tet methylcytosine dioxygenase 2">TET2</a> and three isoforms of <a href="Tet_methylcytosine_dioxygenase_3" title="Tet methylcytosine dioxygenase 3">TET3</a>.<a href="#cite_note-pmid26774490-13">[13]</a><a href="#cite_note-Melamed-14">[14]</a> The full-length canonical TET1 isoform appears virtually restricted to early embryos, embryonic stem cells and primordial germ cells (PGCs). The dominant TET1 isoform in most somatic tissues, at least in the mouse, arises from <a href="Alternative_promoter" class="mw-redirect" title="Alternative promoter">alternative promoter</a> usage which gives rise to a short transcript and a truncated protein designated TET1s. The isoforms of TET3 are the full length form TET3FL, a short form splice variant TET3s, and a form that occurs in oocytes and neurons designated TET3o. TET3o is created by alternative promoter use and contains an additional first <a href="N-terminal" class="mw-redirect" title="N-terminal">N-terminal</a> <a href="Exon" title="Exon">exon</a> coding for 11 <a href="Proteinogenic_amino_acid" title="Proteinogenic amino acid">amino acids</a>. TET3o only occurs in oocytes and neurons and was not expressed in embryonic stem cells or in any other cell type or adult mouse tissue tested. Whereas TET1 expression can barely be detected in oocytes and zygotes, and TET2 is only moderately expressed, the TET3 variant TET3o shows extremely high levels of expression in oocytes and zygotes, but is nearly absent at the 2-cell stage. It is possible that TET3o, high in neurons, oocytes and zygotes at the one cell stage, is the major TET enzyme utilized when very large scale rapid demethylations occur in these cells.

<div class="mw-heading mw-heading3"><h3 id="Recruitment_of_TET_to_DNA">Recruitment of TET to DNA</h3></div>

The <a href="TET_enzymes" title="TET enzymes">TET enzymes</a> do not specifically bind to 5-methylcytosine except when recruited. Without recruitment or targeting, TET1 predominantly binds to high CG promoters and <a href="CpG_island" class="mw-redirect" title="CpG island">CpG islands</a> (CGIs) genome-wide by its CXXC domain that can recognize un-methylated CGIs.<a href="#cite_note-pmid27916660-15">[15]</a> TET2 does not have an affinity for 5-methylcytosine in DNA.<a href="#cite_note-pmid23353889-16">[16]</a> The CXXC domain of the full-length TET3, which is the predominant form expressed in neurons, binds most strongly to CpGs where the C was converted to 5-carboxycytosine (5caC). However, it also binds to un-methylated CpGs.<a href="#cite_note-Melamed-14">[14]</a>

For a <a href="TET_enzymes" title="TET enzymes">TET enzyme</a> to initiate demethylation it must first be recruited to a methylated <a href="CpG_site" title="CpG site">CpG site</a> in DNA. Two of the proteins shown to recruit a TET enzyme to a methylated cytosine in DNA are <a href="Oxoguanine_glycosylase" title="Oxoguanine glycosylase">OGG1</a> (see figure Initiation of DNA demthylation)<a href="#cite_note-Zhou-17">[17]</a> and <a href="EGR1" title="EGR1">EGR1</a>.<a href="#cite_note-pmid31467272-18">[18]</a>

<a href="Oxoguanine_glycosylase" title="Oxoguanine glycosylase">Oxoguanine glycosylase</a> (OGG1) catalyses the first step in base excision repair of the oxidatively damaged base <a href="8-Oxo-2'-deoxyguanosine" title="8-Oxo-2'-deoxyguanosine">8-OHdG</a>. OGG1 finds 8-OHdG by sliding along the linear DNA at 1,000 base pairs of DNA in 0.1 seconds.<a href="#cite_note-pmid16585517-19">[19]</a> OGG1 very rapidly finds 8-OHdG. OGG1 proteins bind to oxidatively damaged DNA with a half maximum time of about 6 seconds.<a href="#cite_note-pmid25539916-20">[20]</a> When OGG1 finds 8-OHdG it changes conformation and complexes with 8-OHdG in the binding pocket of OGG1.<a href="#cite_note-pmid14752045-21">[21]</a> OGG1 does not immediately act to remove the 8-OHdG. Half maximum removal of 8-OHdG takes about 30 minutes in <a href="HeLa_cell" class="mw-redirect" title="HeLa cell">HeLa cells</a> in vitro,<a href="#cite_note-pmid15365186-22">[22]</a> or about 11 minutes in the livers of <a href="Irradiated" class="mw-redirect" title="Irradiated">irradiated</a> mice.<a href="#cite_note-pmid11353081-23">[23]</a> DNA oxidation by <a href="Reactive_oxygen_species" title="Reactive oxygen species">reactive oxygen species</a> preferentially occurs at a <a href="Guanine" title="Guanine">guanine</a> in a methylated CpG site, because of a lowered <a href="Ionization_potential" class="mw-redirect" title="Ionization potential">ionization potential</a> of guanine bases adjacent to 5-methylcytosine.<a href="#cite_note-pmid24571128-24">[24]</a> TET1 binds (is recruited to) the OGG1 bound to 8-OHdG (see figure).<a href="#cite_note-Zhou-17">[17]</a> This likely allows TET1 to demethylate an adjacent methylated cytosine. When human <a href="Mammary" class="mw-redirect" title="Mammary">mammary</a> <a href="Epithelial_cell" class="mw-redirect" title="Epithelial cell">epithelial cells</a> (MCF-10A) were treated with <a href="Hydrogen_peroxide" title="Hydrogen peroxide">H2O2</a>, 8-OHdG increased in DNA by 3.5-fold and this caused large scale demethylation of 5-methylcytosine to about 20% of its initial level in DNA.<a href="#cite_note-Zhou-17">[17]</a>

The gene early growth response protein 1 (<a href="EGR1" title="EGR1">EGR1</a>) is an <a href="Immediate_early_gene" title="Immediate early gene">immediate early gene</a> (IEG). The defining characteristic of IEGs is the rapid and transient up-regulation—within minutes—of their mRNA levels independent of protein synthesis.<a href="#cite_note-Duclot-25">[25]</a> EGR1 can rapidly be induced by neuronal activity.<a href="#cite_note-Sun-26">[26]</a> In adulthood, EGR1 is expressed widely throughout the brain, maintaining baseline expression levels in several key areas of the brain including the <a href="Medial_prefrontal_cortex" class="mw-redirect" title="Medial prefrontal cortex">medial prefrontal cortex</a>, <a href="Striatum" title="Striatum">striatum</a>, hippocampus and <a href="Amygdala" title="Amygdala">amygdala</a>.<a href="#cite_note-Duclot-25">[25]</a> This expression is linked to control of cognition, emotional response, social behavior and sensitivity to reward.<a href="#cite_note-Duclot-25">[25]</a> EGR1 binds to DNA at sites with the <a href="Sequence_motif" title="Sequence motif">motifs</a> 5′-GCGTGGGCG-3′ and 5'-GCGGGGGCGG-3′ and these motifs occur primarily in promoter regions of genes.<a href="#cite_note-Sun-26">[26]</a> The short isoform TET1s is expressed in the brain. EGR1 and TET1s form a complex mediated by the <a href="C-terminal" class="mw-redirect" title="C-terminal">C-terminal</a> regions of both proteins, independently of association with DNA.<a href="#cite_note-Sun-26">[26]</a> EGR1 recruits TET1s to genomic regions flanking EGR1 binding sites.<a href="#cite_note-Sun-26">[26]</a> In the presence of EGR1, TET1s is capable of locus-specific demethylation and activation of the expression of downstream genes regulated by EGR1.<a href="#cite_note-Sun-26">[26]</a>

<div class="mw-heading mw-heading2"><h2 id="History">History</h2></div>

The first person to successfully demonstrate reprogramming was <a href="John_Gurdon" title="John Gurdon">John Gurdon</a>, who in 1962 demonstrated that differentiated somatic cells could be reprogrammed back into an embryonic state when he managed to obtain swimming tadpoles following the transfer of differentiated intestinal epithelial cells into enucleated frog eggs.<a href="#cite_note-Gurdon-1962-27">[27]</a> For this achievement he received the 2012 <a href="Nobel_Prize_in_Medicine" class="mw-redirect" title="Nobel Prize in Medicine">Nobel Prize in Medicine</a> alongside <a href="Shinya_Yamanaka" title="Shinya Yamanaka">Shinya Yamanaka</a>.<a href="#cite_note-28">[28]</a> Yamanaka was the first to demonstrate (in 2006) that this somatic cell nuclear transfer or oocyte-based reprogramming process (see below), that Gurdon discovered, could be recapitulated (in mice) by defined factors (<a href="Oct4" class="mw-redirect" title="Oct4">Oct4</a>, <a href="Sox2" class="mw-redirect" title="Sox2">Sox2</a>, <a href="Klf4" class="mw-redirect" title="Klf4">Klf4</a>, and <a href="C-Myc" class="mw-redirect" title="C-Myc">c-Myc</a>) to generate <a href="Induced_pluripotent_stem_cell" title="Induced pluripotent stem cell">induced pluripotent stem cells</a> (iPSCs).<a href="#cite_note-Takahashi-2006-29">[29]</a> Other combinations of genes have also been used, including LIN25<a href="#cite_note-de_Magalhães-2022-30">[30]</a> and <a href="Homeobox_protein_NANOG" title="Homeobox protein NANOG">Homeobox protein NANOG</a>.<a href="#cite_note-de_Magalhães-2022-30">[30]</a><a href="#cite_note-31">[31]</a>

<div class="mw-heading mw-heading2"><h2 id="Phases_of_reprogramming">Phases of reprogramming</h2></div>

With the discovery that cell fate could be altered, the question of what progression of events occurs signifies a cell undergoing reprogramming. As the final product of iPSC reprogramming was similar in <a href="Morphology_(biology)" title="Morphology (biology)">morphology</a>, proliferation, <a href="Gene_expression" title="Gene expression">gene expression</a>, <a href="Pluripotency_(biological_compounds)" title="Pluripotency (biological compounds)">pluripotency</a>, and <a href="Telomerase" title="Telomerase">telomerase</a> activity, genetic and morphological markers were used as a way to determine what phase of reprogramming was occurring.<a href="#cite_note-Takahashi-2007-32">[32]</a> Reprogramming is defined into three phase: initiation, maturation, and stabilization.<a href="#cite_note-David-2014-33">[33]</a>

<div class="mw-heading mw-heading3"><h3 id="Initiation">Initiation</h3></div>

The initiation phase is associated with the downregulation of cell type specific genes and the upregulation of pluripotent genes.<a href="#cite_note-David-2014-33">[33]</a> As the cells move towards pluripotency, the <a href="Telomerase" title="Telomerase">telomerase</a> activity is reactivated to extend <a href="Telomere" title="Telomere">telomeres</a>. The cell morphology can directly affect the reprogramming process as the cell is modifying itself to prepare for the gene expression of pluripotency.<a href="#cite_note-34">[34]</a> The main indicator that the initiation phase has completed is that the first genes associated with pluripotency are expressed. This includes the expression of <a href="Oct-4" title="Oct-4">Oct-4</a> or <a href="Homeobox_protein_NANOG" title="Homeobox protein NANOG">Homeobox protein NANOG</a>, while undergoing a <a href="Mesenchymal%E2%80%93epithelial_transition" title="Mesenchymal–epithelial transition">mesenchymal–epithelial transition</a> (MET), and the loss of <a href="Apoptosis" title="Apoptosis">apoptosis</a> and <a href="Senescence" title="Senescence">senescence</a>.<a href="#cite_note-Pires-2019-35">[35]</a>

If the cell is directly reprogrammed from one <a href="Somatic_cell" title="Somatic cell">somatic cell</a> to another, the genes associated with each cell type begin to be upregulated and downregulated accordingly.<a href="#cite_note-David-2014-33">[33]</a> This can either occur through direct cell reprogramming or creating an intermediate, such as a iPSC, and differentiating into the desired cell type.<a href="#cite_note-Pires-2019-35">[35]</a>

The initiation phase is completed through one of three pathways: <a href="Nuclear_transfer" title="Nuclear transfer">nuclear transfer</a>, <a href="Cell_fusion" title="Cell fusion">cell fusion</a>, or defined factors (<a href="MicroRNA" title="MicroRNA">microRNA</a>, <a href="Transcription_factor" title="Transcription factor">transcription factor</a>, epigenetic markers, and other small molecules).<a href="#cite_note-de_Magalhães-2022-30">[30]</a><a href="#cite_note-Pires-2019-35">[35]</a>

<div class="mw-heading mw-heading4"><h4 id="Somatic_cell_nuclear_transfer">Somatic cell nuclear transfer</h4></div>

<div role="note" class="hatnote navigation-not-searchable">See also: <a href="Cloning" title="Cloning">cloning</a></div>

An <a href="Oocyte" title="Oocyte">oocyte</a> can reprogram an adult nucleus into an embryonic state after <a href="Somatic_cell_nuclear_transfer" title="Somatic cell nuclear transfer">somatic cell nuclear transfer</a>, so that a new organism can be developed from such cell.<a href="#cite_note-Hochedlinger-2006-36">[36]</a>

Reprogramming is distinct from development of a <a href="Somatic_epitype" title="Somatic epitype">somatic epitype</a>,<a href="#cite_note-37">[37]</a> as somatic epitypes can potentially be altered after an organism has left the developmental stage of life.<a href="#cite_note-38">[38]</a> During somatic cell nuclear transfer, the oocyte turns off tissue specific genes in the somatic cell nucleus and turns back on embryonic specific genes. This process has been shown through cloning, as seen through <a href="John_Gurdon" title="John Gurdon">John Gurdon</a> with the tadpoles<a href="#cite_note-Gurdon-1962-27">[27]</a> and <a href="Dolly_(sheep)" title="Dolly (sheep)">Dolly the Sheep</a>.<a href="#cite_note-39">[39]</a> Notably, these events have shown that cell fate is a reversible process.

<div class="mw-heading mw-heading4"><h4 id="Cell_fusion">Cell fusion</h4></div>

<a href="Cell_fusion" title="Cell fusion">Cell fusion</a> is used to create a multi nucleated cell called a <a href="Heterokaryon" title="Heterokaryon">heterokaryon</a>.<a href="#cite_note-Pires-2019-35">[35]</a> The fused cells allow for otherwise silenced genes to become reactivated and expressive. As the genes are reactivated, the cells can re-differentiate. There are instances where transcriptional factors, such as the Yamanaka factors, are still needed to aid in <a href="Heterokaryon" title="Heterokaryon">heterokaryon</a> cell reprogramming.<a href="#cite_note-40">[40]</a>

<div class="mw-heading mw-heading4"><h4 id="Defined_factors">Defined factors</h4></div>

Unlike nuclear transfer and cell fusion, defined factors do not require a full genome, only reprogramming factors. These reprogramming factors include <a href="MicroRNA" title="MicroRNA">microRNA</a>, <a href="Transcription_factor" title="Transcription factor">transcription factor</a>, epigenetic markers, and other small molecules.<a href="#cite_note-Pires-2019-35">[35]</a> The original transcription factors, that lead to iPSC development, discovered by Yamanaka include <a href="Oct4" class="mw-redirect" title="Oct4">Oct4</a>, <a href="Sox2" class="mw-redirect" title="Sox2">Sox2</a>, <a href="Klf4" class="mw-redirect" title="Klf4">Klf4</a>, and <a href="C-Myc" class="mw-redirect" title="C-Myc">c-Myc</a> (OSKM factors).<a href="#cite_note-Takahashi-2006-29">[29]</a><a href="#cite_note-Takahashi-2007-32">[32]</a> Although the OSKM factors have been shown to induce and aid in pluripotency, other transcription factors such as <a href="Homeobox_protein_NANOG" title="Homeobox protein NANOG">Homeobox protein NANOG</a>,<a href="#cite_note-Bueno-2016-41">[41]</a> LIN25,<a href="#cite_note-de_Magalhães-2022-30">[30]</a> TRA-1-60,<a href="#cite_note-Bueno-2016-41">[41]</a> and C/EBPα<a href="#cite_note-Srivastava-2016-42">[42]</a> aid in the efficiency of reprogramming. The use of <a href="MicroRNA" title="MicroRNA">microRNA</a> and other small molecule-driven processes has been utilized as a means of increasing the efficiency of the differentiation from somatic cells to pluripotency.<a href="#cite_note-Pires-2019-35">[35]</a>

<div class="mw-heading mw-heading3"><h3 id="Maturation">Maturation</h3></div>

The maturation phase begins at the end of the initiation phase, when the first pluripotent genes are expressed.<a href="#cite_note-David-2014-33">[33]</a> The cell is preparing itself to be independent from the defined factors, that started the reprogramming process. The first genes to be detected in iPSCs are <a href="Oct4" class="mw-redirect" title="Oct4">Oct4</a>, <a href="Homeobox_protein_NANOG" title="Homeobox protein NANOG">Homeobox protein NANOG</a>, and Esrrb, followed later by <a href="Sox2" class="mw-redirect" title="Sox2">Sox2</a>.<a href="#cite_note-Pires-2019-35">[35]</a> In the later stages of maturation, <a href="Transgene" title="Transgene">transgene</a> silencing marks the start of the cell becoming independent from the induced <a href="Transcription_factor" title="Transcription factor">transcription factor</a>. Once the cell is independent, the maturation phase ends and the stabilization phase begins.

As reprogramming efficiency has proven to be a variable and low efficiency process, not all the cells complete the maturation phase and achieve <a href="Pluripotency_(biological_compounds)" title="Pluripotency (biological compounds)">pluripotency</a>.<a href="#cite_note-Srivastava-2016-42">[42]</a> Some cells that undergo reprogramming still remain under <a href="Apoptosis" title="Apoptosis">apoptosis</a> at the beginning of the maturation stage from <a href="Oxidative_stress" title="Oxidative stress">oxidative stress</a> brought on by the stresses of gene expression change. The use of <a href="MicroRNA" title="MicroRNA">microRNA</a>, proteins, and different combinations of the OSKM factors have started to lead towards a higher efficiency rate of reprogramming.

<div class="mw-heading mw-heading3"><h3 id="Stabilization">Stabilization</h3></div>

The stabilization phase refers to the processes in the cell that occur after the cell reaches <a href="Pluripotency_(biological_compounds)" title="Pluripotency (biological compounds)">pluripotency</a>. One genetic marker is the expression of <a href="Sox2" class="mw-redirect" title="Sox2">Sox2</a> and <a href="X_chromosome" title="X chromosome">X chromosome</a> <a href="X-chromosome_reactivation" title="X-chromosome reactivation">reactivation</a>, while epigenetic changes include the <a href="Telomerase" title="Telomerase">telomerase</a> extending the <a href="Telomere" title="Telomere">telomeres</a><a href="#cite_note-de_Magalhães-2022-30">[30]</a> and loss of the cell’s epigenetic memory.<a href="#cite_note-David-2014-33">[33]</a> The epigenetic memory of a cell is reset by the changes in DNA methylation,<a href="#cite_note-43">[43]</a> using <a href="Activation-induced_cytidine_deaminase" title="Activation-induced cytidine deaminase">activation-induced cytidine deaminase</a> (AID), <a href="TET_enzymes" title="TET enzymes">TET enzymes</a> (TET), and <a href="DNA_methyltransferase" title="DNA methyltransferase">DNA methyltransferase</a> (DMNTs), starting in the maturation phase and into the stabilization stage.<a href="#cite_note-David-2014-33">[33]</a> Once the epigenetic memory of the cell is lost, the possibility of differentiation into the three germ layers is achieved.<a href="#cite_note-Takahashi-2007-32">[32]</a> This is considered a fully reprogrammed cell as it can be passaged without reverting to its original somatic cell type.<a href="#cite_note-Pires-2019-35">[35]</a>

<div class="mw-heading mw-heading2"><h2 id="In_cell_culture_systems">In cell culture systems</h2></div>

Reprogramming can also be induced artificially through the introduction of exogenous factors, usually <a href="Transcription_factor" title="Transcription factor">transcription factors</a>. In this context, it often refers to the creation of <a href="Induced_pluripotent_stem_cell" title="Induced pluripotent stem cell">induced pluripotent stem cells</a> from mature cells such as adult <a href="Fibroblast" title="Fibroblast">fibroblasts</a>. This allows the production of <a href="Stem_cell" title="Stem cell">stem cells</a> for <a href="Biomedical_research" class="mw-redirect" title="Biomedical research">biomedical research</a>, such as research into <a href="Stem-cell_therapy" title="Stem-cell therapy">stem cell therapies</a>, without the use of embryos. It is carried out by the <a href="Transfection" title="Transfection">transfection</a> of stem-cell associated genes into mature cells using <a href="Viral_vector" title="Viral vector">viral vectors</a> such as <a href="Retrovirus" title="Retrovirus">retroviruses</a>.

<div class="mw-heading mw-heading3"><h3 id="Transcription_factors">Transcription factors</h3></div>

One of the first transacting factors discovered to change a cell was found in a myoblast when the <a href="Complementary_DNA" title="Complementary DNA">complementary DNA</a> (cDNA) coding for <a href="MyoD" title="MyoD">MyoD</a> was expressed and converted a <a href="Fibroblast" title="Fibroblast">fibroblast</a> to a myoblast. Another transacting factor that directly transformed a <a href="Lymphoid_cell" class="mw-redirect" title="Lymphoid cell">lymphoid cell</a> into a <a href="Myeloid_cell" class="mw-redirect" title="Myeloid cell">myeloid cell</a> was C/EBPα. MyoD and C/EBPα are examples of a small number of single factors that can transform cells. More often, a combination of transcription factors work in conjunction to reprogram a cell.

The OSKM factors (<a href="Oct4" class="mw-redirect" title="Oct4">Oct4</a>, <a href="Sox2" class="mw-redirect" title="Sox2">Sox2</a>, <a href="Klf4" class="mw-redirect" title="Klf4">Klf4</a>, and <a href="C-Myc" class="mw-redirect" title="C-Myc">c-Myc</a>) were initially discovered by Yamanaka in 2006, by the induction of a mouse fibroblast into an <a href="Induced_pluripotent_stem_cell" title="Induced pluripotent stem cell">induced pluripotent stem cell</a> (iPSCs).<a href="#cite_note-Takahashi-2006-29">[29]</a> Within the following year, these factors were used to induce human fibroblasts into iPSCs.<a href="#cite_note-Takahashi-2007-32">[32]</a>

<a href="Oct4" class="mw-redirect" title="Oct4">Oct4</a> is part of the core regulatory genes needed for pluripotency, as it is seen in both <a href="Embryonic_stem_cell" title="Embryonic stem cell">embryonic stem cells</a> and tumors.<a href="#cite_note-Rizzino-2009-44">[44]</a> The use of Oct4 even in small increases allows for the start differentiation into pluripotency. Oct4 works in conjecture with Sox2 for the expression of <a href="FGF4" title="FGF4">FGF4</a> which could aid in differentiation.

<a href="Sox2" class="mw-redirect" title="Sox2">Sox2</a> is a gene used in maintaining pluripotency in stem cells. Oct4 and Sox2 work together to regulate hundreds of genes utilized in pluripotency.<a href="#cite_note-Rizzino-2009-44">[44]</a> However, Sox2 is not the only possible Sox family member to participate in gene regulation with Oct4 – <a href="SOX4" title="SOX4">Sox4</a>, <a href="SOX11" title="SOX11">Sox11</a>, and <a href="SOX15" title="SOX15">Sox15</a> also participate, as the Sox protein is redundant throughout the stem cell <a href="Genome" title="Genome">genome</a>.

<a href="Klf4" class="mw-redirect" title="Klf4">Klf4</a> is a transcription factor used in <a href="Cell_proliferation" title="Cell proliferation">proliferation</a>, <a href="Cellular_differentiation" title="Cellular differentiation">differentiation</a>, <a href="Apoptosis" title="Apoptosis">apoptosis</a>, and <a href="Somatic_cell" title="Somatic cell">somatic cell</a> reprogramming. When being utilized in cellular reprogramming, Klf4 prevents cell division of damaged cells using its apoptotic ability, and aids in <a href="Histone_acetyltransferase" title="Histone acetyltransferase">histone acetyltransferase</a> activity.<a href="#cite_note-Takahashi-2007-32">[32]</a>

<a href="C-Myc" class="mw-redirect" title="C-Myc">c-Myc</a> is also known as an <a href="Oncogene" title="Oncogene">oncogene</a>, and in certain conditions can become cancer causing.<a href="#cite_note-45">[45]</a> In cellular reprogramming, c-Myc is used for <a href="Cell_cycle" title="Cell cycle">cell cycle</a> progression, <a href="Apoptosis" title="Apoptosis">apoptosis</a>, and cellular transformation for further differentiation.

<div class="mw-heading mw-heading4"><h4 id="NANOG">NANOG</h4></div>

<a href="Homeobox_protein_NANOG" title="Homeobox protein NANOG">Homeobox protein NANOG</a> (NANOG) is a transcription factor used to aid in the efficiency of generating iPSCs by maintaining <a href="Cell_potency#Pluripotency" title="Cell potency">pluripotency</a><a href="#cite_note-46">[46]</a> and suppressing <a href="Cell_fate_determination" title="Cell fate determination">cell determination factors</a>.<a href="#cite_note-47">[47]</a> NANOG works by promoting <a href="Chromatin" title="Chromatin">chromatin</a> accessibility through repression of <a href="Histone" title="Histone">histone</a> markers, such as <a href="H3K27me3" title="H3K27me3">H3K27me3</a>. NANOG aids recruitment of <a href="Oct4" class="mw-redirect" title="Oct4">Oct4</a>, <a href="Sox2" class="mw-redirect" title="Sox2">Sox2</a>, and Esrrb used in <a href="Transcription_(biology)" title="Transcription (biology)">transcription</a>, while also recruiting <a href="SMARCA4" title="SMARCA4">Brahma-related gene-1</a> (BRG1) for <a href="Chromatin" title="Chromatin">chromatin</a> accessibility.

<a href="CEBPA" title="CEBPA">CEBPA</a> is a commonly used factor when reprogramming cells into not only iPSCs, but also other cells. C/EBPα has shown itself to be a single transacting factor during direct reprogramming of a lymphoid cell into a myeloid cell.<a href="#cite_note-Srivastava-2016-42">[42]</a> C/EBPα is considered a 'path breaker' to aid in preparing the cell for intake of the OSKM factors and specific transcription events.<a href="#cite_note-Bueno-2016-41">[41]</a> C/EBPα has also been shown to increase the efficiency of the reprogramming events.<a href="#cite_note-David-2014-33">[33]</a>

<div class="mw-heading mw-heading2"><h2 id="Variability">Variability</h2></div>

The properties of cells obtained after reprogramming can vary significantly, in particular among iPSCs.<a href="#cite_note-Paull-2015-48">[48]</a> Factors leading to variation in the performance of reprogramming and functional features of end products include genetic background, tissue source, reprogramming factor stoichiometry and stressors related to cell culture.<a href="#cite_note-Paull-2015-48">[48]</a>

<ul><li>Induced stem cells</li>

<li><a href="Epigenome_editing" title="Epigenome editing">Epigenome editing</a></li></ul>

<div class="mw-heading mw-heading2"><h2 id="References">References</h2></div>

/* start https://en.wikipedia.org/ */

.mw-parser-output .reflist{margin-bottom:0.5em;list-style-type:decimal}@media screen{.mw-parser-output .reflist{font-size:90%}}.mw-parser-output .reflist .references{font-size:100%;margin-bottom:0;list-style-type:inherit}.mw-parser-output .reflist-columns-2{column-width:30em}.mw-parser-output .reflist-columns-3{column-width:25em}.mw-parser-output .reflist-columns{margin-top:0.3em}.mw-parser-output .reflist-columns ol{margin-top:0}.mw-parser-output .reflist-columns li{page-break-inside:avoid;break-inside:avoid-column}.mw-parser-output .reflist-upper-alpha{list-style-type:upper-alpha}.mw-parser-output .reflist-upper-roman{list-style-type:upper-roman}.mw-parser-output .reflist-lower-alpha{list-style-type:lower-alpha}.mw-parser-output .reflist-lower-greek{list-style-type:lower-greek}.mw-parser-output .reflist-lower-roman{list-style-type:lower-roman}

/* end https://en.wikipedia.org/ */

</style><div class="reflist">

/* start https://en.wikipedia.org/ */

.mw-parser-output cite.citation{font-style:inherit;word-wrap:break-word}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .citation:target{background-color:rgba(0,127,255,0.133)}.mw-parser-output .id-lock-free.id-lock-free a{background:url("./mw/Lock-green.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-limited.id-lock-limited a,.mw-parser-output .id-lock-registration.id-lock-registration a{background:url("./mw/Lock-gray-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-subscription.id-lock-subscription a{background:url("./mw/Lock-red-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .cs1-ws-icon a{background:url("./mw/Wikisource-logo.svg")right 0.1em center/12px no-repeat}body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .id-lock-free a,body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .id-lock-limited a,body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .id-lock-registration a,body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .id-lock-subscription a,body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .cs1-ws-icon a{background-size:contain;padding:0 1em 0 0}.mw-parser-output .cs1-code{color:inherit;background:inherit;border:none;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;color:var(--color-error,#d33)}.mw-parser-output .cs1-visible-error{color:var(--color-error,#d33)}.mw-parser-output .cs1-maint{display:none;color:#085;margin-left:0.3em}.mw-parser-output .cs1-kern-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}@media screen{.mw-parser-output .cs1-format{font-size:95%}html.skin-theme-clientpref-night .mw-parser-output .cs1-maint{color:#18911f}}@media screen and (prefers-color-scheme:dark){html.skin-theme-clientpref-os .mw-parser-output .cs1-maint{color:#18911f}}

/* end https://en.wikipedia.org/ */

</style><cite id="CITEREFReikDeanWalter2001" class="citation journal cs1">Reik W, Dean W, Walter J (August 2001). "Epigenetic reprogramming in mammalian development". Science (Review). 293 (5532): 1089–1093. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1126%2Fscience.1063443">10.1126/science.1063443</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/11498579">11498579</a>. <a href="S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:17089710">17089710</a>.</cite>

</li>

<li id="cite_note-2"><a href="#cite_ref-2">^</a> <cite id="CITEREFCedarBergman2012" class="citation journal cs1">Cedar H, Bergman Y (July 2012). <a rel="nofollow" class="external text" href="https://zenodo.org/record/894035">"Programming of DNA methylation patterns"</a>. Annual Review of Biochemistry. 81: 97–117. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1146%2Fannurev-biochem-052610-091920">10.1146/annurev-biochem-052610-091920</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/22404632">22404632</a>.</cite>

</li>

<li id="cite_note-pmid25476147-3"><a href="#cite_ref-pmid25476147_3-0">^</a> <cite id="CITEREFAuclairGuibertBenderWeber2014" class="citation journal cs1">Auclair G, Guibert S, Bender A, Weber M (2014). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295324">"Ontogeny of CpG island methylation and specificity of DNMT3 methyltransferases during embryonic development in the mouse"</a>. Genome Biology. 15 (12): 545. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1186%2Fs13059-014-0545-5">10.1186/s13059-014-0545-5</a>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295324">4295324</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/25476147">25476147</a>.</cite>

</li>

<li id="cite_note-Zeng-4"><a href="#cite_ref-Zeng_4-0">^</a> <cite id="CITEREFZengChen2019" class="citation journal cs1">Zeng Y, Chen T (March 2019). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6523607">"DNA Methylation Reprogramming during Mammalian Development"</a>. Genes. 10 (4): 257. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3390%2Fgenes10040257">10.3390/genes10040257</a>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6523607">6523607</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30934924">30934924</a>.</cite>

</li>

<li id="cite_note-pmid27916276-5"><a href="#cite_ref-pmid27916276_5-0">^</a> <cite id="CITEREFLadstätterTachibana-Konwalski2016" class="citation journal cs1">Ladstätter S, Tachibana-Konwalski K (December 2016). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5161750">"A Surveillance Mechanism Ensures Repair of DNA Lesions during Zygotic Reprogramming"</a>. Cell. 167 (7): 1774–1787.e13. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.cell.2016.11.009">10.1016/j.cell.2016.11.009</a>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5161750">5161750</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27916276">27916276</a>.</cite>

</li>

<li id="cite_note-pmid23166394-6"><a href="#cite_ref-pmid23166394_6-0">^</a> <cite id="CITEREFSeisenbergerPeatHoreSantos2013" class="citation journal cs1">Seisenberger S, Peat JR, Hore TA, Santos F, Dean W, Reik W (January 2013). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3539359">"Reprogramming DNA methylation in the mammalian life cycle: building and breaking epigenetic barriers"</a>. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 368 (1609): 20110330. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1098%2Frstb.2011.0330">10.1098/rstb.2011.0330</a>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3539359">3539359</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23166394">23166394</a>.</cite>

</li>

<li id="cite_note-7"><a href="#cite_ref-7">^</a> <cite id="CITEREFMannChungNolenVerona2003" class="citation journal cs1">Mann MR, Chung YG, Nolen LD, Verona RI, Latham KE, Bartolomei MS (September 2003). <a rel="nofollow" class="external text" href="https://doi.org/10.1095%2Fbiolreprod.103.017293">"Disruption of imprinted gene methylation and expression in cloned preimplantation stage mouse embryos"</a>. Biology of Reproduction. 69 (3): 902–914. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1095%2Fbiolreprod.103.017293">10.1095/biolreprod.103.017293</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/12748125">12748125</a>.</cite>

</li>

<li id="cite_note-8"><a href="#cite_ref-8">^</a> <cite id="CITEREFWrenzyckiNiemann2003" class="citation journal cs1">Wrenzycki C, Niemann H (December 2003). "Epigenetic reprogramming in early embryonic development: effects of in-vitro production and somatic nuclear transfer". Review. Reproductive Biomedicine Online. 7 (6): 649–656. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fs1472-6483%2810%2962087-1">10.1016/s1472-6483(10)62087-1</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/14748963">14748963</a>.</cite>

</li>

<li id="cite_note-pmid28620075-9"><a href="#cite_ref-pmid28620075_9-0">^</a> <cite id="CITEREFDukeKennedyGavinDay2017" class="citation journal cs1">Duke CG, Kennedy AJ, Gavin CF, Day JJ, Sweatt JD (July 2017). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473107">"Experience-dependent epigenomic reorganization in the hippocampus"</a>. Learning & Memory. 24 (7): 278–288. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1101%2Flm.045112.117">10.1101/lm.045112.117</a>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473107">5473107</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28620075">28620075</a>.</cite>

</li>

<li id="cite_note-pmid16120461-10"><a href="#cite_ref-pmid16120461_10-0">^</a> <cite id="CITEREFKimJung2006" class="citation journal cs1">Kim JJ, Jung MW (2006). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342048">"Neural circuits and mechanisms involved in Pavlovian fear conditioning: a critical review"</a>. Neuroscience and Biobehavioral Reviews. 30 (2): 188–202. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.neubiorev.2005.06.005">10.1016/j.neubiorev.2005.06.005</a>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342048">4342048</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/16120461">16120461</a>.</cite>

</li>

<li id="cite_note-pmid29875631-11"><a href="#cite_ref-pmid29875631_11-0">^</a> <cite id="CITEREFBayraktarKreutz2018" class="citation journal cs1">Bayraktar G, Kreutz MR (2018). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975432">"The Role of Activity-Dependent DNA Demethylation in the Adult Brain and in Neurological Disorders"</a>. Frontiers in Molecular Neuroscience. 11: 169. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3389%2Ffnmol.2018.00169">10.3389/fnmol.2018.00169</a>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975432">5975432</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29875631">29875631</a>.</cite>

</li>

<li id="cite_note-Bayraktar-12">^ <a href="#cite_ref-Bayraktar_12-0">a</a> <a href="#cite_ref-Bayraktar_12-1">b</a> <cite id="CITEREFBayraktarKreutz2018" class="citation journal cs1">Bayraktar G, Kreutz MR (2018). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975432">"The Role of Activity-Dependent DNA Demethylation in the Adult Brain and in Neurological Disorders"</a>. Frontiers in Molecular Neuroscience. 11: 169. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3389%2Ffnmol.2018.00169">10.3389/fnmol.2018.00169</a>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975432">5975432</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29875631">29875631</a>.</cite>

</li>

<li id="cite_note-pmid26774490-13"><a href="#cite_ref-pmid26774490_13-0">^</a> <cite id="CITEREFJinZhangDunwellHarter2016" class="citation journal cs1">Jin SG, Zhang ZM, Dunwell TL, Harter MR, Wu X, Johnson J, et al. (January 2016). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731272">"Tet3 Reads 5-Carboxylcytosine through Its CXXC Domain and Is a Potential Guardian against Neurodegeneration"</a>. Cell Reports. 14 (3): 493–505. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.celrep.2015.12.044">10.1016/j.celrep.2015.12.044</a>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731272">4731272</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26774490">26774490</a>.</cite>

</li>

<li id="cite_note-Melamed-14">^ <a href="#cite_ref-Melamed_14-0">a</a> <a href="#cite_ref-Melamed_14-1">b</a> <cite id="CITEREFMelamedYosefzonDavidTsukerman2018" class="citation journal cs1">Melamed P, Yosefzon Y, David C, Tsukerman A, Pnueli L (2018). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844914">"Tet Enzymes, Variants, and Differential Effects on Function"</a>. Frontiers in Cell and Developmental Biology. 6: 22. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3389%2Ffcell.2018.00022">10.3389/fcell.2018.00022</a>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844914">5844914</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29556496">29556496</a>.</cite>

</li>

<li id="cite_note-pmid27916660-15"><a href="#cite_ref-pmid27916660_15-0">^</a> <cite id="CITEREFZhangXiaWangTowers2016" class="citation journal cs1">Zhang W, Xia W, Wang Q, Towers AJ, Chen J, Gao R, et al. (December 2016). <a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.molcel.2016.10.030">"Isoform Switch of TET1 Regulates DNA Demethylation and Mouse Development"</a>. Molecular Cell. 64 (6): 1062–1073. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.molcel.2016.10.030">10.1016/j.molcel.2016.10.030</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27916660">27916660</a>.</cite>

</li>

<li id="cite_note-pmid23353889-16"><a href="#cite_ref-pmid23353889_16-0">^</a> <cite id="CITEREFDeplusDelatteSchwinnDefrance2013" class="citation journal cs1">Deplus R, Delatte B, Schwinn MK, Defrance M, Méndez J, Murphy N, et al. (March 2013). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590984">"TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS"</a>. The EMBO Journal. 32 (5): 645–655. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Femboj.2012.357">10.1038/emboj.2012.357</a>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590984">3590984</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23353889">23353889</a>.</cite>

</li>

<li id="cite_note-Zhou-17">^ <a href="#cite_ref-Zhou_17-0">a</a> <a href="#cite_ref-Zhou_17-1">b</a> <a href="#cite_ref-Zhou_17-2">c</a> <a href="#cite_ref-Zhou_17-3">d</a> <cite id="CITEREFZhouZhuangWangHe2016" class="citation journal cs1">Zhou X, Zhuang Z, Wang W, He L, Wu H, Cao Y, et al. (September 2016). "OGG1 is essential in oxidative stress induced DNA demethylation". Cellular Signalling. 28 (9): 1163–1171. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.cellsig.2016.05.021">10.1016/j.cellsig.2016.05.021</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27251462">27251462</a>.</cite>

</li>

<li id="cite_note-pmid31467272-18"><a href="#cite_ref-pmid31467272_18-0">^</a> <cite id="CITEREFSunXuHeMurray2019" class="citation journal cs1">Sun Z, Xu X, He J, Murray A, Sun MA, Wei X, et al. (August 2019). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6715719">"EGR1 recruits TET1 to shape the brain methylome during development and upon neuronal activity"</a>. Nature Communications. 10 (1): 3892. <a href="Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/2019NatCo..10.3892S">2019NatCo..10.3892S</a>. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fs41467-019-11905-3">10.1038/s41467-019-11905-3</a>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6715719">6715719</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/31467272">31467272</a>.</cite>

</li>

<li id="cite_note-pmid16585517-19"><a href="#cite_ref-pmid16585517_19-0">^</a> <cite id="CITEREFBlaineyvan_OijenBanerjeeVerdine2006" class="citation journal cs1">Blainey PC, van Oijen AM, Banerjee A, Verdine GL, Xie XS (April 2006). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1458645">"A base-excision DNA-repair protein finds intrahelical lesion bases by fast sliding in contact with DNA"</a>. Proceedings of the National Academy of Sciences of the United States of America. 103 (15): 5752–5757. <a href="Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/2006PNAS..103.5752B">2006PNAS..103.5752B</a>. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1073%2Fpnas.0509723103">10.1073/pnas.0509723103</a>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1458645">1458645</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/16585517">16585517</a>.</cite>

</li>

<li id="cite_note-pmid25539916-20"><a href="#cite_ref-pmid25539916_20-0">^</a> <cite id="CITEREFAbdouPoirierHendzelWeinfeld2015" class="citation journal cs1">Abdou I, Poirier GG, Hendzel MJ, Weinfeld M (January 2015). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4333375">"DNA ligase III acts as a DNA strand break sensor in the cellular orchestration of DNA strand break repair"</a>. Nucleic Acids Research. 43 (2): 875–892. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fnar%2Fgku1307">10.1093/nar/gku1307</a>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4333375">4333375</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/25539916">25539916</a>.</cite>

</li>

<li id="cite_note-pmid14752045-21"><a href="#cite_ref-pmid14752045_21-0">^</a> <cite id="CITEREFvan_der_KempCharbonnierAudebertBoiteux2004" class="citation journal cs1">van der Kemp PA, Charbonnier JB, Audebert M, Boiteux S (2004). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC373348">"Catalytic and DNA-binding properties of the human Ogg1 DNA N-glycosylase/AP lyase: biochemical exploration of H270, Q315 and F319, three amino acids of the 8-oxoguanine-binding pocket"</a>. Nucleic Acids Research. 32 (2): 570–578. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fnar%2Fgkh224">10.1093/nar/gkh224</a>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC373348">373348</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/14752045">14752045</a>.</cite>

</li>

<li id="cite_note-pmid15365186-22"><a href="#cite_ref-pmid15365186_22-0">^</a> <cite id="CITEREFLanNakajimaOohataTakao2004" class="citation journal cs1">Lan L, Nakajima S, Oohata Y, Takao M, Okano S, Masutani M, et al. (September 2004). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC518826">"In situ analysis of repair processes for oxidative DNA damage in mammalian cells"</a>. Proceedings of the National Academy of Sciences of the United States of America. 101 (38): 13738–13743. <a href="Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/2004PNAS..10113738L">2004PNAS..10113738L</a>. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1073%2Fpnas.0406048101">10.1073/pnas.0406048101</a>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC518826">518826</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/15365186">15365186</a>.</cite>

</li>

<li id="cite_note-pmid11353081-23"><a href="#cite_ref-pmid11353081_23-0">^</a> <cite id="CITEREFHamiltonGuoFullerVan_Remmen2001" class="citation journal cs1">Hamilton ML, Guo Z, Fuller CD, Van Remmen H, Ward WF, Austad SN, et al. (May 2001). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC55450">"A reliable assessment of 8-oxo-2-deoxyguanosine levels in nuclear and mitochondrial DNA using the sodium iodide method to isolate DNA"</a>. Nucleic Acids Research. 29 (10): 2117–2126. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fnar%2F29.10.2117">10.1093/nar/29.10.2117</a>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC55450">55450</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/11353081">11353081</a>.</cite>

</li>

<li id="cite_note-pmid24571128-24"><a href="#cite_ref-pmid24571128_24-0">^</a> <cite id="CITEREFMingMatterSongVeliath2014" class="citation journal cs1">Ming X, Matter B, Song M, Veliath E, Shanley R, Jones R, Tretyakova N (March 2014). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3985951">"Mapping structurally defined guanine oxidation products along DNA duplexes: influence of local sequence context and endogenous cytosine methylation"</a>. Journal of the American Chemical Society. 136 (11): 4223–4235. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1021%2Fja411636j">10.1021/ja411636j</a>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3985951">3985951</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/24571128">24571128</a>.</cite>

</li>

<li id="cite_note-Duclot-25">^ <a href="#cite_ref-Duclot_25-0">a</a> <a href="#cite_ref-Duclot_25-1">b</a> <a href="#cite_ref-Duclot_25-2">c</a> <cite id="CITEREFDuclotKabbaj2017" class="citation journal cs1">Duclot F, Kabbaj M (2017). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337695">"The Role of Early Growth Response 1 (EGR1) in Brain Plasticity and Neuropsychiatric Disorders"</a>. Frontiers in Behavioral Neuroscience. 11: 35. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3389%2Ffnbeh.2017.00035">10.3389/fnbeh.2017.00035</a>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337695">5337695</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28321184">28321184</a>.</cite>

</li>

<li id="cite_note-Sun-26">^ <a href="#cite_ref-Sun_26-0">a</a> <a href="#cite_ref-Sun_26-1">b</a> <a href="#cite_ref-Sun_26-2">c</a> <a href="#cite_ref-Sun_26-3">d</a> <a href="#cite_ref-Sun_26-4">e</a> <cite id="CITEREFSunXuHeMurray2019" class="citation journal cs1">Sun Z, Xu X, He J, Murray A, Sun MA, Wei X, et al. (August 2019). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6715719">"EGR1 recruits TET1 to shape the brain methylome during development and upon neuronal activity"</a>. Nature Communications. 10 (1): 3892. <a href="Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/2019NatCo..10.3892S">2019NatCo..10.3892S</a>. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fs41467-019-11905-3">10.1038/s41467-019-11905-3</a>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6715719">6715719</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/31467272">31467272</a>.</cite>

</li>

<li id="cite_note-Gurdon-1962-27">^ <a href="#cite_ref-Gurdon-1962_27-0">a</a> <a href="#cite_ref-Gurdon-1962_27-1">b</a> <cite id="CITEREFGurdon1962" class="citation journal cs1">Gurdon JB (December 1962). "The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles". Journal of Embryology and Experimental Morphology. 10: 622–640. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/13951335">13951335</a>.</cite>

</li>

<li id="cite_note-28"><a href="#cite_ref-28">^</a> <cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.nobelprize.org/nobel_prizes/medicine/laureates/2012/press.html">"The Nobel Prize in Physiology or Medicine – 2012 Press Release"</a>. Nobel Media AB. 8 October 2012.</cite>

</li>

<li id="cite_note-Takahashi-2006-29">^ <a href="#cite_ref-Takahashi-2006_29-0">a</a> <a href="#cite_ref-Takahashi-2006_29-1">b</a> <a href="#cite_ref-Takahashi-2006_29-2">c</a> <cite id="CITEREFTakahashiYamanaka2006" class="citation journal cs1">Takahashi K, <a href="Shinya_Yamanaka" title="Shinya Yamanaka">Yamanaka S</a> (August 2006). <a rel="nofollow" class="external text" href="http://repository.kulib.kyoto-u.ac.jp/dspace/bitstream/2433/159777/1/j.cell.2006.07.024.pdf">"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors"</a> (PDF). Cell. 126 (4): 663–676. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.cell.2006.07.024">10.1016/j.cell.2006.07.024</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/16904174">16904174</a>. <a href="S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:1565219">1565219</a>.</cite>

</li>

<li id="cite_note-de_Magalhães-2022-30">^ <a href="#cite_ref-de_Magalhães-2022_30-0">a</a> <a href="#cite_ref-de_Magalhães-2022_30-1">b</a> <a href="#cite_ref-de_Magalhães-2022_30-2">c</a> <a href="#cite_ref-de_Magalhães-2022_30-3">d</a> <a href="#cite_ref-de_Magalhães-2022_30-4">e</a> <a href="#cite_ref-de_Magalhães-2022_30-5">f</a> <cite id="CITEREFde_MagalhãesOcampo2022" class="citation journal cs1">de Magalhães JP, Ocampo A (June 2022). <a rel="nofollow" class="external text" href="http://pure-oai.bham.ac.uk/ws/files/170576357/rejuvenation_TIB_revised.pdf">"Cellular reprogramming and the rise of rejuvenation biotech"</a> (PDF). Trends in Biotechnology. 40 (6): 639–642. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.tibtech.2022.01.011">10.1016/j.tibtech.2022.01.011</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/35190201">35190201</a>. <a href="S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:246990346">246990346</a>.</cite>

</li>

<li id="cite_note-31"><a href="#cite_ref-31">^</a> <cite id="CITEREFSayginTabibBittarValenzi2007" class="citation journal cs1">Saygin D, Tabib T, Bittar HE, Valenzi E, Sembrat J, Chan SY, et al. (2007-12-06). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052475">"Transcriptional profiling of lung cell populations in idiopathic pulmonary arterial hypertension"</a>. Pulmonary Circulation. 10 (1). <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fstemcells.2007.124">10.1038/stemcells.2007.124</a>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052475">7052475</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/32166015">32166015</a>.</cite>

</li>

<li id="cite_note-Takahashi-2007-32">^ <a href="#cite_ref-Takahashi-2007_32-0">a</a> <a href="#cite_ref-Takahashi-2007_32-1">b</a> <a href="#cite_ref-Takahashi-2007_32-2">c</a> <a href="#cite_ref-Takahashi-2007_32-3">d</a> <a href="#cite_ref-Takahashi-2007_32-4">e</a> <cite id="CITEREFTakahashiTanabeOhnukiNarita2007" class="citation journal cs1">Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (November 2007). "Induction of pluripotent stem cells from adult human fibroblasts by defined factors". Cell. 131 (5): 861–872. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.cell.2007.11.019">10.1016/j.cell.2007.11.019</a>. <a href="Hdl_(identifier)" class="mw-redirect" title="Hdl (identifier)">hdl</a>:<a rel="nofollow" class="external text" href="https://hdl.handle.net/2433%2F49782">2433/49782</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/18035408">18035408</a>. <a href="S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:8531539">8531539</a>.</cite>

</li>

<li id="cite_note-David-2014-33">^ <a href="#cite_ref-David-2014_33-0">a</a> <a href="#cite_ref-David-2014_33-1">b</a> <a href="#cite_ref-David-2014_33-2">c</a> <a href="#cite_ref-David-2014_33-3">d</a> <a href="#cite_ref-David-2014_33-4">e</a> <a href="#cite_ref-David-2014_33-5">f</a> <a href="#cite_ref-David-2014_33-6">g</a> <a href="#cite_ref-David-2014_33-7">h</a> <cite id="CITEREFDavidPolo2014" class="citation journal cs1">David L, Polo JM (May 2014). <a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.scr.2014.03.007">"Phases of reprogramming"</a>. Stem Cell Research. 12 (3): 754–761. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.scr.2014.03.007">10.1016/j.scr.2014.03.007</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/24735951">24735951</a>. <a href="S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:31759309">31759309</a>.</cite>

</li>

<li id="cite_note-34"><a href="#cite_ref-34">^</a> <cite id="CITEREFDowningSotoMorezHoussin2013" class="citation journal cs1">Downing TL, Soto J, Morez C, Houssin T, Fritz A, Yuan F, et al. (December 2013). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675045">"Biophysical regulation of epigenetic state and cell reprogramming"</a>. Nature Materials. 12 (12): 1154–1162. <a href="Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/2013NatMa..12.1154D">2013NatMa..12.1154D</a>. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fnmat3777">10.1038/nmat3777</a>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675045">9675045</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/24141451">24141451</a>.</cite>

</li>

<li id="cite_note-Pires-2019-35">^ <a href="#cite_ref-Pires-2019_35-0">a</a> <a href="#cite_ref-Pires-2019_35-1">b</a> <a href="#cite_ref-Pires-2019_35-2">c</a> <a href="#cite_ref-Pires-2019_35-3">d</a> <a href="#cite_ref-Pires-2019_35-4">e</a> <a href="#cite_ref-Pires-2019_35-5">f</a> <a href="#cite_ref-Pires-2019_35-6">g</a> <a href="#cite_ref-Pires-2019_35-7">h</a> <a href="#cite_ref-Pires-2019_35-8">i</a> <a href="#cite_ref-Pires-2019_35-9">j</a> <a href="#cite_ref-Pires-2019_35-10">k</a> <a href="#cite_ref-Pires-2019_35-11">l</a> <cite id="CITEREFPiresRosaKurochkinPereira2019" class="citation journal cs1">Pires CF, Rosa FF, Kurochkin I, Pereira CF (2019-12-11). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC917620">"Understanding and Modulating Immunity With Cell Reprogramming"</a>. Frontiers in Immunology. 10: 2809. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3389%2Ffimmu.2019.02809">10.3389/fimmu.2019.02809</a>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC917620">917620</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/31921109">31921109</a>.</cite>

</li>

<li id="cite_note-Hochedlinger-2006-36">^ <a href="#cite_ref-Hochedlinger-2006_36-0">a</a> <a href="#cite_ref-Hochedlinger-2006_36-1">b</a> <cite id="CITEREFHochedlingerJaenisch2006" class="citation journal cs1">Hochedlinger K, Jaenisch R (June 2006). "Nuclear reprogramming and pluripotency". Nature. 441 (7097): 1061–1067. <a href="Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/2006Natur.441.1061H">2006Natur.441.1061H</a>. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fnature04955">10.1038/nature04955</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/16810240">16810240</a>. <a href="S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:4304218">4304218</a>.</cite>

</li>

<li id="cite_note-37"><a href="#cite_ref-37">^</a> <cite id="CITEREFSayginTabibBittarValenzi2006" class="citation journal cs1">Saygin D, Tabib T, Bittar HE, Valenzi E, Sembrat J, Chan SY, et al. (2006). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052475">"Transcriptional profiling of lung cell populations in idiopathic pulmonary arterial hypertension"</a>. Pulmonary Circulation. 10 (1): 976. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fnrn2022-c1">10.1038/nrn2022-c1</a>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052475">7052475</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/32166015">32166015</a>.</cite>

</li>

<li id="cite_note-38"><a href="#cite_ref-38">^</a> <cite id="CITEREFMathers2006" class="citation journal cs1">Mathers JC (June 2006). "Nutritional modulation of ageing: genomic and epigenetic approaches". Mechanisms of Ageing and Development. 127 (6): 584–589. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.mad.2006.01.018">10.1016/j.mad.2006.01.018</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/16513160">16513160</a>. <a href="S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:9187848">9187848</a>.</cite>

</li>

<li id="cite_note-39"><a href="#cite_ref-39">^</a> <cite id="CITEREFWilmutSchniekeMcWhirKind1997" class="citation journal cs1">Wilmut I, Schnieke AE, McWhir J, Kind AJ, Campbell KH (February 1997). "Viable offspring derived from fetal and adult mammalian cells". Nature. 385 (6619): 810–813. <a href="Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/1997Natur.385..810W">1997Natur.385..810W</a>. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2F385810a0">10.1038/385810a0</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/9039911">9039911</a>.</cite>

</li>

<li id="cite_note-40"><a href="#cite_ref-40">^</a> <cite id="CITEREFPereiraTerranovaRyanSantos2008" class="citation journal cs1">Pereira CF, Terranova R, Ryan NK, Santos J, Morris KJ, Cui W, et al. (September 2008). Roopenian DC (ed.). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2527997">"Heterokaryon-based reprogramming of human B lymphocytes for pluripotency requires Oct4 but not Sox2"</a>. PLOS Genetics. 4 (9): e1000170. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1371%2Fjournal.pgen.1000170">10.1371/journal.pgen.1000170</a>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2527997">2527997</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/18773085">18773085</a>.</cite>

</li>

<li id="cite_note-Bueno-2016-41">^ <a href="#cite_ref-Bueno-2016_41-0">a</a> <a href="#cite_ref-Bueno-2016_41-1">b</a> <a href="#cite_ref-Bueno-2016_41-2">c</a> <cite id="CITEREFBuenoSardinaDi_StefanoRomero-Moya2016" class="citation journal cs1">Bueno C, Sardina JL, Di Stefano B, Romero-Moya D, Muñoz-López A, Ariza L, et al. (March 2016). "Reprogramming human B cells into induced pluripotent stem cells and its enhancement by C/EBPα". Leukemia. 30 (3): 674–682. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fleu.2015.294">10.1038/leu.2015.294</a>. <a href="Hdl_(identifier)" class="mw-redirect" title="Hdl (identifier)">hdl</a>:<a rel="nofollow" class="external text" href="https://hdl.handle.net/10651%2F43469">10651/43469</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26500142">26500142</a>. <a href="S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:508334">508334</a>.</cite>

</li>

<li id="cite_note-Srivastava-2016-42">^ <a href="#cite_ref-Srivastava-2016_42-0">a</a> <a href="#cite_ref-Srivastava-2016_42-1">b</a> <a href="#cite_ref-Srivastava-2016_42-2">c</a> <cite id="CITEREFSrivastavaDeWitt2016" class="citation journal cs1">Srivastava D, DeWitt N (September 2016). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234007">"In Vivo Cellular Reprogramming: The Next Generation"</a>. Cell. 166 (6): 1386–1396. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.cell.2016.08.055">10.1016/j.cell.2016.08.055</a>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234007">6234007</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27610565">27610565</a>.</cite>

</li>

<li id="cite_note-43"><a href="#cite_ref-43">^</a> <cite id="CITEREFPoloAnderssenWalshSchwarz2012" class="citation journal cs1">Polo JM, Anderssen E, Walsh RM, Schwarz BA, Nefzger CM, Lim SM, et al. (December 2012). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608203">"A molecular roadmap of reprogramming somatic cells into iPS cells"</a>. Cell. 151 (7): 1617–1632. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.cell.2012.11.039">10.1016/j.cell.2012.11.039</a>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608203">3608203</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23260147">23260147</a>.</cite>

</li>

<li id="cite_note-Rizzino-2009-44">^ <a href="#cite_ref-Rizzino-2009_44-0">a</a> <a href="#cite_ref-Rizzino-2009_44-1">b</a> <cite id="CITEREFRizzino2009" class="citation journal cs1">Rizzino A (December 2009). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2794141">"Sox2 and Oct-3/4: a versatile pair of master regulators that orchestrate the self-renewal and pluripotency of embryonic stem cells"</a>. Wiley Interdisciplinary Reviews. Systems Biology and Medicine. 1 (2): 228–236. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fwsbm.12">10.1002/wsbm.12</a>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2794141">2794141</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/20016762">20016762</a>.</cite>

</li>

<li id="cite_note-45"><a href="#cite_ref-45">^</a> <cite id="CITEREFDominguez-SolaYingGrandoriRuggiero2007" class="citation journal cs1">Dominguez-Sola D, Ying CY, Grandori C, Ruggiero L, Chen B, Li M, et al. (July 2007). "Non-transcriptional control of DNA replication by c-Myc". Nature. 448 (7152): 445–451. <a href="Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/2007Natur.448..445D">2007Natur.448..445D</a>. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fnature05953">10.1038/nature05953</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/17597761">17597761</a>. <a href="S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:4422771">4422771</a>.</cite>

</li>

<li id="cite_note-46"><a href="#cite_ref-46">^</a> <cite id="CITEREFZaehresLenschDaheronStewart2005" class="citation journal cs1">Zaehres H, Lensch MW, Daheron L, Stewart SA, Itskovitz-Eldor J, Daley GQ (March 2005). <a rel="nofollow" class="external text" href="https://doi.org/10.1634%2Fstemcells.2004-0252">"High-efficiency RNA interference in human embryonic stem cells"</a>. Stem Cells. 23 (3): 299–305. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1634%2Fstemcells.2004-0252">10.1634/stemcells.2004-0252</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/15749924">15749924</a>. <a href="S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:1395518">1395518</a>.</cite>

</li>

<li id="cite_note-47"><a href="#cite_ref-47">^</a> <cite id="CITEREFHeurtierOwensGonzalezMueller2019" class="citation journal cs1">Heurtier V, Owens N, Gonzalez I, Mueller F, Proux C, Mornico D, et al. (March 2019). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406003">"The molecular logic of Nanog-induced self-renewal in mouse embryonic stem cells"</a>. Nature Communications. 10 (1): 1109. <a href="Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/2019NatCo..10.1109H">2019NatCo..10.1109H</a>. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fs41467-019-09041-z">10.1038/s41467-019-09041-z</a>. <a href="PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a> <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406003">6406003</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30846691">30846691</a>.</cite>

</li>

<li id="cite_note-Paull-2015-48">^ <a href="#cite_ref-Paull-2015_48-0">a</a> <a href="#cite_ref-Paull-2015_48-1">b</a> <cite id="CITEREFPaullSevillaZhouHahn2015" class="citation journal cs1">Paull D, Sevilla A, Zhou H, Hahn AK, Kim H, Napolitano C, et al. (September 2015). "Automated, high-throughput derivation, characterization and differentiation of induced pluripotent stem cells". Nature Methods. 12 (9): 885–892. <a href="Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fnmeth.3507">10.1038/nmeth.3507</a>. <a href="PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a> <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26237226">26237226</a>. <a href="S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a> <a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:9889991">9889991</a>.</cite>

</li>

</ol></div></div></div><div><div class="zim-footer">

This article is issued from <a class="external text" title="Last edited on 2025-04-24" href="https://en.wikipedia.org/wiki/?title=Reprogramming&oldid=1287225862">Wikipedia</a>. The text is available under <a class="external text" href="https://creativecommons.org/licenses/by-sa/4.0/deed.en">Creative Commons Attribution-Share Alike 4.0</a> unless otherwise noted. Additional terms may apply for the media files.

</div>

</div></div>

</div>

</main>

</div>

</body></html>